127 related articles for article (PubMed ID: 32979792)
1. Recent progress on nanoparticles for targeted aneurysm treatment and imaging.
Yodsanit N; Wang B; Zhao Y; Guo LW; Kent KC; Gong S
Biomaterials; 2021 Jan; 265():120406. PubMed ID: 32979792
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis-Guided Rational Engineering of Nanotherapies for the Targeted Treatment of Abdominal Aortic Aneurysm by Inhibiting Neutrophilic Inflammation.
Hu K; Zhong L; Lin W; Zhao G; Pu W; Feng Z; Zhou M; Ding J; Zhang J
ACS Nano; 2024 Feb; 18(8):6650-6672. PubMed ID: 38369729
[TBL] [Abstract][Full Text] [Related]
3. Assessing the targeting and fate of cathepsin k antibody-modified nanoparticles in a rat abdominal aortic aneurysm model.
Camardo A; Carney S; Ramamurthi A
Acta Biomater; 2020 Aug; 112():225-233. PubMed ID: 32504690
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Extracellular Matrix in Abdominal Aortic Aneurysms Using Molecular Imaging Insights.
Adams L; Brangsch J; Hamm B; Makowski MR; Keller S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799971
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles that target degraded elastin improve imaging and rupture prediction in an AngII mediated mouse model of abdominal aortic aneurysm.
Wang X; Lane BA; Eberth JF; Lessner SM; Vyavahare NR
Theranostics; 2019; 9(14):4156-4167. PubMed ID: 31281538
[No Abstract] [Full Text] [Related]
6. Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update.
Wang YD; Liu ZJ; Ren J; Xiang MX
Curr Vasc Pharmacol; 2018 Jan; 16(2):114-124. PubMed ID: 28412911
[TBL] [Abstract][Full Text] [Related]
7. Pentagalloyl Glucose-Laden Poly(lactide-
Arnold F; Muzzio N; Patnaik SS; Finol EA; Romero G
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25771-25782. PubMed ID: 34030437
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-Assisted Diagnosis and Treatment for Abdominal Aortic Aneurysm.
Yin L; Zhang K; Sun Y; Liu Z
Front Med (Lausanne); 2021; 8():665846. PubMed ID: 34307401
[TBL] [Abstract][Full Text] [Related]
9. Inflammation as a Predictor of Abdominal Aortic Aneurysm Growth and Rupture: A Systematic Review of Imaging Biomarkers.
Jalalzadeh H; Indrakusuma R; Planken RN; Legemate DA; Koelemay MJ; Balm R
Eur J Vasc Endovasc Surg; 2016 Sep; 52(3):333-42. PubMed ID: 27283346
[TBL] [Abstract][Full Text] [Related]
10. Assessing trans-endothelial transport of nanoparticles for delivery to abdominal aortic aneurysms.
Yau J; Chukwu P; Jedlicka SS; Ramamurthi A
J Biomed Mater Res A; 2024 Jun; 112(6):881-894. PubMed ID: 38192169
[TBL] [Abstract][Full Text] [Related]
11. Systemic Delivery of Nanoparticles Loaded with Pentagalloyl Glucose Protects Elastic Lamina and Prevents Abdominal Aortic Aneurysm in Rats.
Nosoudi N; Chowdhury A; Siclari S; Parasaram V; Karamched S; Vyavahare N
J Cardiovasc Transl Res; 2016 Dec; 9(5-6):445-455. PubMed ID: 27542007
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic PLGA nanoparticles for slow clot lysis within abdominal aortic aneurysms attenuate proteolytic loss of vascular elastic matrix.
Sivaraman B; Sylvester A; Ramamurthi A
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():145-156. PubMed ID: 26652359
[TBL] [Abstract][Full Text] [Related]
13. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.
Aoki H; Yoshimura K; Matsuzaki M
J Mol Med (Berl); 2007 Oct; 85(10):1077-88. PubMed ID: 17522832
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles Effectively Target Rapamycin Delivery to Sites of Experimental Aortic Aneurysm in Rats.
Shirasu T; Koyama H; Miura Y; Hoshina K; Kataoka K; Watanabe T
PLoS One; 2016; 11(6):e0157813. PubMed ID: 27336852
[TBL] [Abstract][Full Text] [Related]
15. Concurrent Molecular Magnetic Resonance Imaging of Inflammatory Activity and Extracellular Matrix Degradation for the Prediction of Aneurysm Rupture.
Brangsch J; Reimann C; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Buchholz R; Karst U; Botnar RM; Hamm B; Makowski MR
Circ Cardiovasc Imaging; 2019 Mar; 12(3):e008707. PubMed ID: 30871334
[TBL] [Abstract][Full Text] [Related]
16. A Modified Murine Abdominal Aortic Aneurysm Rupture Model Using Elastase Perfusion and Angiotensin II Infusion.
Yue J; Yin L; Shen J; Liu Z
Ann Vasc Surg; 2020 Aug; 67():474-481. PubMed ID: 32171859
[TBL] [Abstract][Full Text] [Related]
17. Potential Medication Treatment According to Pathological Mechanisms in Abdominal Aortic Aneurysm.
Zhang SL; Du X; Chen YQ; Tan YS; Liu L
J Cardiovasc Pharmacol; 2018 Jan; 71(1):46-57. PubMed ID: 28953105
[TBL] [Abstract][Full Text] [Related]
18. Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.
Yoshimura K; Morikage N; Nishino-Fujimoto S; Furutani A; Shirasawa B; Hamano K
Curr Drug Targets; 2018; 19(11):1265-1275. PubMed ID: 29284386
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion.
Li G; Qin L; Wang L; Li X; Caulk AW; Zhang J; Chen PY; Xin S
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1110-H1119. PubMed ID: 28213405
[TBL] [Abstract][Full Text] [Related]
20. Serum Calprotectin as a Novel Biomarker in Abdominal Aortic Aneurysm Pathogenesis and Progression: Preliminary Data from Experimental Model in Rats.
Moris D; Theocharis S; Davakis S; Patelis N; Agrogiannis G; Vlachos IS; Spartalis E; Athanasiou A; Bakoyiannis C; Perrea DN; Georgopoulos S
Curr Vasc Pharmacol; 2018 Jan; 16(2):168-178. PubMed ID: 28155626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
